Vaccination News

Paxlovid was associated with a significant reduction in 30-day hospitalization or death among previously uninfected patients with COVID-19 who were not hospitalized, researchers found.

Adults hospitalized with COVID-19 were less likely to experience critical outcomes such as ICU admission, respiratory failure or death during later periods of the pandemic, researchers found.

The CDC recently recommended updated versions of the Moderna and Pfizer-BioNTech COVID-19 vaccines aimed at omicron XBB subvariants of SARS-CoV-2, following their approval by the FDA.

Outreach efforts in the form of text messages and phone calls succeeded in increasing COVID-19 vaccination among children with sickle cell disease, according to a study published in Pediatrics.

A chatbot-delivered, personally tailored intervention was associated with increased uptake in seasonal influenza vaccinations among older adults, a study in JAMA Network Open showed.

Roughly one-third of men globally have at least one type of genital HPV and one in five are infected with at least one high-risk HPV type, according to the results of a systematic review and meta-analysis.

The CDC on Tuesday recommended the updated monovalent COVID-19 vaccines for people aged older than 6 months.

The FDA on Monday approved and authorized updated COVID-19 vaccines from Moderna and Pfizer-BioNTech that target omicron XBB subvariants of SARS-CoV-2.

PHILADELPHIA — In this video, Paul A. Offit, MD, discusses a panel at the World Anti-Microbial Resistance Congress and Disease Prevention & Control Summit that covered vaccine safety.

A fourth dose of a bivalent COVID-19 vaccine provided added protection for previously infected and SARS-CoV-2 naïve patients compared with a fourth dose of a monovalent vaccine, researchers in Singapore found.